Search for: "TEVA PHARMACEUTICAL INDUSTRIES LTD" Results 101 - 120 of 256
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Mar 2013, 9:39 pm by Patent Docs
• Defendants: Teva Pharmaceutical Industries, Ltd.; Teva Pharmaceuticals USA, Inc. [read post]
30 Nov 2012, 6:00 am by Gene Quinn
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
30 Nov 2012, 6:00 am by Gene Quinn
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
13 Nov 2012, 5:43 pm by John W. Arden
The European Commission (EC) announced on November 12 that it has cleared Procter & Gamble Company's proposed acquisition of the over-the-counter (OTC) business of the generic pharmaceutical company Teva Pharmaceutical Industries, Ltd. of Israel. [read post]
11 Sep 2012, 5:30 am by Gene Quinn
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
3 Aug 2012, 1:56 pm by Joe Palazzolo
The Securities and Exchange Commission is investigating Teva Pharmaceutical Industries Ltd, the world’s largest manufacturer of generic drugs, for possible violations of a U.S. anti-bribery law. [read post]
1 Jun 2012, 1:58 pm by Gene Quinn
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®ShareTweetTeva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
5 Apr 2012, 11:54 am by Bexis
Teva Pharmaceuticals USA, Inc., 2011 WL 4025734, at *3 (S.D. [read post]
24 Mar 2012, 1:20 pm by Stewart Walsh
CAFC Rules “Secret Prior Art” Requires Only Appreciation that Invention Made in Teva Pharmaceutical*The doctrines of “secret prior art” and “inherency” both merged in the case Teva Pharmaceutical Industries Ltd. v. [read post]
21 Mar 2012, 11:32 am
The ruling, which was a victory for Mylan Inc.'s UDL Laboratories, Actavis Inc., and Teva Pharmaceutical Industries Ltd. by a 5-4 vote, overturned appeals court decisions that allowed for such complaints. [read post]
11 Mar 2012, 8:16 pm by Reproductive Rights
Bloomberg: Teva Pharmaceutical Seeks to Intervene in Plan B Lawsuit, by Thom Weidlich: Teva Pharmaceutical Industries Ltd. [read post]
29 Jan 2012, 2:08 pm
Teva Pharmaceutical Industries Ltd. and its U.S. subsidiary Cephalon has recalled a lot of its Treanda leukemia drug, because glass fragments were found in one of the vials. [read post]
29 Jan 2012, 2:08 pm
Teva Pharmaceutical Industries Ltd. and its U.S. subsidiary Cephalon has recalled a lot of its Treanda leukemia drug, because glass fragments were found in one of the vials. [read post]
4 Dec 2011, 8:46 am by Eric Guttag
The doctrines of “secret prior art” and “inherency” both merged in the case Teva Pharmaceutical Industries Ltd. v. [read post]
1 Dec 2011, 7:40 pm by Rantanen
By Jason Rantanen Teva Pharmaceutical Industries Ltd. v. [read post]
3 Nov 2011, 9:55 am by Aaron Barkoff
  Subsequently, LEO Pharma sought to amend its complaint to, among other things, add Teva Pharmaceutical Industries Ltd. as a defendant. [read post]